Anti-CD4 protein monoclonal antibody and its active fragment and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- XIAMEN UNIV
- Publication Date
- 2014-10-08
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to a monoclonal antibody that can specifically bind to a human surface antigen differentiation cluster 4 (Cluster of Differentiation 4, CD4) protein, a conservative variant or an active fragment thereof, and a related coding sequence of a polypeptide or a polypeptide analog thereof, to produce the Cell lines of monoclonal antibodies, and methods and uses of the antibodies or fragments for prevention, immunotherapy and diagnosis; prevention or treatment of primates, including humans, whose source of infection is CD4 + Diseases caused by the main target cells of cells: These diseases include acquired immunodeficiency syndrome (AIDS, AIDS), AIDS-related diseases, and human immunodeficiency virus (human immunodeficiency virus, HIV) infection. Background technique
[0002] Since the discovery of HIV in the last century, many researchers have devoted themselves to research on HIV molecular biology, immunity, and vaccines. How...